Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|September 10, 2013
Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patientsHye Ryun Kim, Hyung Soon Park, Woo Sun Kwon, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 26, 2015
Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic studyEisuke Booka, Chiyo K Imamura, Hiroya Takeuchi, et al.Cancer Chemotherapy and Pharmacology|July 13, 2022
Prospective evaluation of the relationship between response and exposure of total and unbound erlotinib in non-small cell lung cancer patientsHirotsugu Kenmotsu, Chiyo K Imamura, Takahisa Kawamura, et al.Clinical Pharmacology and Therapeutics|June 21, 2018
Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil TherapyJan H Beumer, Edward Chu, Carmen Allegra, et al.Clinical Lung Cancer|September 4, 2017
Clinical Factors Predicting Detection of T790M Mutation in Rebiopsy for EGFR-Mutant Non-small-cell Lung CancerTakahisa Kawamura, Hirotsugu Kenmotsu, Shota Omori, et al.Cancer Science|December 5, 2020
Prospective evaluation and refinement of an S-1 dosage formula based on renal function for clinical applicationMasashi Takeuchi, Chiyo K Imamura, Eisuke Booka, et al.BMC Cancer|July 19, 2024
Definitive chemoradiotherapy with paclitaxel for locally advanced esophageal squamous cell carcinoma in older patients (PARADISE-1): a phase I trialKenro Hirata, Kayo Yoshida, Chikatoshi Katada, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2019
CYP2D6 Genotype-Guided Tamoxifen Dosing in Hormone Receptor-Positive Metastatic Breast Cancer (TARGET-1): A Randomized, Open-Label, Phase II StudyKenji Tamura, Chiyo K Imamura, Toshimi Takano, et al.Oncology Reports|February 2, 2012
Expression changes in arrestin β 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patientsHiromichi Matsuoka, Tokuzo Arao, Chihiro Makimura, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 4, 2014
Clinical practice guidelines for therapeutic drug monitoring of arbekacin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug MonitoringKenji Okada, Toshimi Kimura, Hiroshige Mikamo, et al.Pageof 10